Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    Not Rated
  • Minimum Investment
    ₹1000
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹237 Cr
  • Created on
    2 May 2021
Fund Ranking
#11
/ 17 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    14.6%
  • 1 Year
    11.8%
  • 3 Year (CAGR)
    19.4%
  • All Time (CAGR)
    13.3%
Category Return
  • 6 Month
    18.4%
  • 1 Year
    13.5%
  • 3 Year (CAGR)
    20.1%
  • All Time (CAGR)
    16.9%
Asset Allocation
  • Equity
    100.0%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    7.88%
  • Aurobindo Pharma
    4.09%
  • Cipla
    6.82%
  • Dr. Reddy's Laboratories
    6.05%
  • Ipca Laboratories
    2.36%
Fund Information
  • Expense Ratio
    0.18%
  • Exit Load
    No Exit Load
  • Lock-In Period
    No Lock-In

Managed By

Kewal Shah
Feb 2024 - Present
Priya Sridhar
Feb 2024 - Present
Kayzad Eghlim
May 2021 - Present
Nishit Patel
May 2021 - Present
Ashwini Jemin Bharucha
Nov 2024 - Present
Venus Ahuja
Nov 2025 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.78
  • Standard Deviation
    16.81
  • Alpha
    -1.89
  • Beta
    0.99